PROCEPT BioRobotics Obtains $42,000,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c3b33d19-5d3c-4d35-96bd-a1ed8bc7362b - Date
7/8/2015 - Company Name
PROCEPT BioRobotics - Mailing Address
900 Island Dr. Redwood Shores, CA 94065 USA - Company Description
PROCEPT BioRobotics is a medical device company that develops a novel minimally invasive technology to surgically treat prostate disease. The first product developed is the AquaBeam, an intelligent image-guided robotic system delivering Aquablation, a personalized waterjet tissue resection modality. - Website
http://www.procept-biorobotics.com - Transaction Type
Venture Equity - Transaction Amount
$42,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
PROCEPT will use the proceeds from the financing for a limited commercial launch of AquaBeam in targeted international markets and to conduct the WATER study (Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue), a randomized blinded controlled clinical trial. - M&A Terms
- Venture Investor
- Venture Investor
